In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device/Diagnostics Quarterly Deal Statistics, Q3 2013

A look at financing, M&A, and alliance activity, July–September 2013

Executive Summary

Device and diagnostics companies both suffered declines in fundraising compared with previous quarters. The biggest medtech acquisition was Stryker’s $1.4 billion buyout of MAKO, while in diagnostics BioMeriux’s $450 million purchase of BioFire topped the list.

Advertisement

Related Content

NeuroPace’s RNS For Epilepsy Becomes First FDA-Approved Responsive Neurostimulator
Up Close With Russian Investor Rusnano: A Q&A With Anatoly Chubais
Will Stryker’s MAKO Purchase Bring Disruption To The Ortho Industry?
GSK Venture Fund Selects Neurostim Device Maker SetPoint Medical As First Investment
Foundation Medicine, Ophthotech Enjoy First-Day IPO Pops
Bard Gains Foothold In Home Care Market With Rochester Medical Acquisition
JenaValve Raises $62.5 Million To Fund Transfemoral TAVI Trial And More
Abbott Ups Vascular, Ophthalmic Focus With Two Acquisitions
Zoll Acquires CoAxia Assets In Bid To Revive NeuroFlo Stroke Catheter

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV003981

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel